This is an editorial summary of research originally reported by Google Health News. ProductSafer does not claim ownership of the underlying research. All intellectual property belongs to the original publishers.
Free weekly digest
We track health and safety research on food, cosmetics, and household products and send you what matters. Join 27 readers.
What would you like to do next?
I use this product
Get the next safety alert before it goes viral
Free weekly digest of health findings about everyday products. No spam, unsubscribe any time.
Advertisement
Get the latest health findings delivered to your inbox. Only the important stuff. No spam.
We'll send a confirmation email. Unsubscribe anytime.
A new daily pill called Foundayo helps people keep weight off after stopping obesity injections. In clinical trials, patients who switched from injectable weight-loss drugs to this pill didn't regain significant weight. This matters because it could give people more options for long-term weight management without continuing injections.
# Editorial Summary
Pharmaceutical company Eli Lilly has released results from clinical trials testing orforglipron, a daily pill designed to help people maintain weight loss after stopping injectable obesity medications like Zepbound. The research comes as a response to a real problem faced by patients. Many people who achieve weight loss through GLP-1 injections regain pounds quickly once they stop the treatment. Lilly wanted to know whether switching to a daily pill could help bridge that gap and keep the weight off long-term.
The trial followed patients who had successfully lost weight using higher-dose injectable treatments. Researchers then switched them to either orforglipron, lower-dose Zepbound (the injectable form), or a placebo. The findings showed that patients on the daily pill maintained their weight loss better than those on placebo. They also didn't regain significantly more weight than those who continued the injectable form. This suggests the pill could offer a practical maintenance option for people looking to sustain their results without ongoing injections.
Weight loss medications work best when people use them consistently. The challenge is that obesity drugs are expensive and require ongoing treatment. Many patients struggle with injection fatigue or prefer a daily pill. A maintenance option that's less demanding than regular injections could help more people stick with their treatment. That's why these results matter beyond just the numbers.
If you're considering weight loss medication or currently taking injectable obesity drugs, talk with your doctor about your options. Ask whether a maintenance pill might work for your situation. Keep in mind that any medication is just one part of the picture. Diet, exercise, and lifestyle changes still matter. We'll need to see how this pill performs as it moves toward approval and becomes available to a wider population.
Always consult a healthcare professional for personal medical advice.
Read the full report at the original source
Google Health NewsWas this finding useful?
People over 65 and those from certain ethnic backgrounds struggle to maintain healthy vitamin D levels even during summer months. The problem persists year-round, meaning these groups can't rely on seasonal sun exposure to fix the deficiency.
Community discussion
Join the discussion
Comments are reviewed before appearing publicly.